Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE)

The INCENTIVE project is a partnership between Indian, European and US partners. Its main objective is to advance knowledge of the underlying mechanisms of poor responsiveness to influenza vaccines (IVs) and to develop two next-generation universal IVs.


  • Identifying the mechanisms of vaccine responsiveness by performing comprehensive profiling of responders and non-responders to licensed IVs to identify the mechanisms of vaccine responsiveness;
  • Advancing the development of two next-generation vaccines by providing a proof-of-concept for vaccine efficacy in non-human primates for an antigen presenting cell-targeted nucleic acid vaccine and developing a computationally-optimized vaccine up to phase II clinical trials and vaccine efficacy in a controlled human challenge;
  • Identifying predictive biomarkers of responsiveness to vaccination for new diagnostics;
  • Implementing technology transfer;
  • Health systems and investment analysis.

The project is running from August 1, 2020 until July 21, 2025 and is led by Helmholtz Centre for Infection Research, Germany.

Read more: